SCHEMBL7837513

SCHEMBL7837513

CCOC(=O)C(Cc1cc(OC)c2c(c1)OCO2)NC(=O)CNC(=O)c1cccc(NC=NN)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ABCB1 P08183 2/20 0.38
LMNA P02545 2/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ALDH1A1 P00352 2/20 0.36
CYP3A4 P08684 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
AHR P35869 1/20 0.36
GPR139 Q6DWJ6 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7340265 0.92 ABCB1 (0.41) ABCB1LMNAHSD17B10ALDH1A1CYP3A4
SCHEMBL7825264 0.88 HSD17B10 (0.47) NPC1RAB9ALMNAMAPK1HSD17B10
SCHEMBL7338364 0.84 GPR139 (0.45) NPC1LMNAMAPK1ALDH1A1SMN1; SMN2
SCHEMBL7341748 0.83 TACR1 (0.41) ALDH1A1GPR139MEN1KMT2ATP53
SCHEMBL7836351 0.83 RAB9A (0.42) NPC1RAB9ALMNAMAPK1HSD17B10
SCHEMBL6778100 0.82 ITGB3 (0.42) AHRGPR139
SCHEMBL7825718 0.82 TP53 (0.47) ALDH1A1GPR139MEN1KMT2ATP53
SCHEMBL7339503 0.81 KMT2A (0.42) NPC1RAB9ALMNAALDH1A1SMN1; SMN2
SCHEMBL7823384 0.80 ALDH1A1 (0.40) NPC1RAB9ALMNAALDH1A1SMN1; SMN2
SCHEMBL7838138 0.80 POLB (0.37) NPC1RAB9AALDH1A1GPR139MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP claimed